Cargando…
A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine
Patients with chromoblastomycosis (CBM) usually have a history of local skin damage related to outdoor activities, mainly manifested as chronic refractory proliferative pathologic changes. We report a case of a 56-year-old man with CBM, identified as Fonsecaea pedrosoi infection by fungal culture an...
Autores principales: | Shen, Xu-Cheng, Dai, Xiang-Nong, Xie, Zhi-Min, Li, Ping, Lu, Sha, Li, Jia-Hao, Zhang, Yi, Ye, Xing-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090106/ https://www.ncbi.nlm.nih.gov/pubmed/32086748 http://dx.doi.org/10.1007/s13555-020-00358-y |
Ejemplares similares
-
Chromoblastomycosis Caused by Fonsecaea pedrosoi
por: Kim, Dong Min, et al.
Publicado: (2011) -
Corneal Chromoblastomycosis Caused by Fonsecaea pedrosoi
por: Chaidaroon, Winai, et al.
Publicado: (2015) -
The Major Chromoblastomycosis Etiologic Agent Fonsecaea pedrosoi Activates the NLRP3 Inflammasome
por: de Castro, Raffael Júnio Araújo, et al.
Publicado: (2017) -
Chromoblastomycosis due to Cladosporium langeronii.
Molecular diagnosis of an agent previously diagnosed as Fonsecaea pedrosoi
por: Torres-Guerrero, Edoardo, et al.
Publicado: (2018) -
Biofilm Formation by Chromoblastomycosis Fungi Fonsecaea pedrosoi and Phialophora verrucosa: Involvement with Antifungal Resistance
por: Sousa, Ingrid S., et al.
Publicado: (2022)